more generic ARBs in 2012
You'll see more generic ARBs in 2012...irbesartan (Avapro) in March...valsartan (Diovan) in Sept...and candesartan (Atacand) in Dec.
But don't let this lure you into using them first-line instead of ACE inhibitors. ACEIs still have more evidence for improving outcomes.
When you do use an ARB, expect formularies to force switching from brand to generic.